Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients

por Von Einem, Jobst C, Stintzing, Sebastian, Modest, Dominik P, Wiedemann, Michael, Fürweger, Christoph, Muacevic, Alexander
Publicado 2020

Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review

por Strickler, John H, Yoshino, Takayuki, Stevinson, Kendall, Eichinger, Christian Stefan, Giannopoulou, Christina, Rehn, Marko, Modest, Dominik Paul
Publicado 2023

Incidence of Cancer in Patients with Irritable Bowl Syndrome

por Loosen, Sven H., Jördens, Markus S., Luedde, Mark, Modest, Dominik P., Labuhn, Simon, Luedde, Tom, Kostev, Karel, Roderburg, Christoph
Publicado 2021

Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials

por Modest, Dominik Paul, Rivera, Fernando, Bachet, Jean‐Baptiste, de Braud, Filippo, Pietrantonio, Filippo, Koukakis, Reija, Demonty, Gaston, Douillard, Jean‐Yves
Publicado 2019

Radiotherapeutic treatment options for oligotopic malignant liver lesions

por Wust, Peter, Beck, Marcus, Dabrowski, Robert, Neumann, Oliver, Zschaeck, Sebastian, Kaul, David, Modest, Dominik P., Stromberger, Carmen, Gebauer, Bernhard, Ghadjar, Pirus
Publicado 2021

Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research

por Baechmann, Sibylle, Ormanns, Steffen, Haas, Michael, Kruger, Stephan, Remold, Anna, Modest, Dominik Paul, Kirchner, Thomas, Jung, Andreas, Werner, Jens, Heinemann, Volker, Boeck, Stefan
Publicado 2017

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO...

por Reinacher-Schick, Anke, Schulmann, Karsten, Modest, Dominik P, Bruns, Nina, Graeven, Ulrich, Jaworska, Malgorzata, Greil, Richard, Porschen, Rainer, Arnold, Dirk, Schmiegel, Wolff, Tannapfel, Andrea
Publicado 2012

Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in pati...

por Kehmann, Linde, Berres, Marie-Luise, Gonzalez-Carmona, Maria, Modest, Dominik P., Mohr, Raphael, Wree, Alexander, Venerito, Marino, Strassburg, Christian, Keitel, Verena, Trautwein, Christian, Luedde, Tom, Roderburg, Christoph
Publicado 2023

A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation

por Ossami Saidy, Ramin Raul, Wegener, Elisa, Uluk, Deniz, Dittrich, Luca, Schöning, Wenzel, Lurje, Georg, Öllinger, Robert, Modest, Dominik Paul, Tacke, Frank, Haase, Oliver, Pratschke, Johann, Eurich, Dennis
Publicado 2022

Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials

por Stahler, Arndt, Heinemann, Volker, Ricard, Ingrid, von Einem, Jobst C., Giessen-Jung, Clemens, Westphalen, Christoph Benedikt, Michl, Marlies, Heinrich, Kathrin, Miller-Phillips, Lisa, Jelas, Ivan, Stintzing, Sebastian, Modest, Dominik Paul
Publicado 2020

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

por Striefler, Jana Käthe, Riess, Hanno, Lohneis, Philipp, Bischoff, Sven, Kurreck, Annika, Modest, Dominik Paul, Bahra, Marcus, Oettle, Helmut, Sinn, Marianne, Bläker, Henrik, Denkert, Carsten, Stintzing, Sebastian, Sinn, Bruno Valentin, Pelzer, Uwe
Publicado 2021

Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observati...

por Kurreck, Annika, Gronau, Felix, Alberto Vilchez, Miguel Enrique, Abels, Wiltrud, Enghard, Philipp, Brandl, Andreas, Francis, Roland, Föhre, Bettina, Lojewski, Christian, Pratschke, Johann, Thuss-Patience, Peter, Modest, Dominik, Rau, Beate, Feldbrügge, Linda
Publicado 2021

Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice

por Knitter, Sebastian, Duwe, Gregor, Beierle, Anika Sophie, Pesthy, Sina, Ritschl, Paul Viktor, Hillebrandt, Karl Herbert, Arnold, Alexander, Malinka, Thomas, Modest, Dominik Paul, Bahra, Marcus, Pratschke, Johann, Sauer, Igor Maximilian, Schmelzle, Moritz, Andreou, Andreas
Publicado 2022

Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma

por Lurje, Isabella, Uluk, Deniz, Pavicevic, Sandra, Phan, Minh Duc, Eurich, Dennis, Fehrenbach, Uli, Geisel, Dominik, Auer, Timo Alexander, Pelzer, Uwe, Modest, Dominik Paul, Raschzok, Nathanael, Sauer, Igor Maximilian, Schöning, Wenzel, Tacke, Frank, Pratschke, Johann, Lurje, Georg
Publicado 2023

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

por von Einem, Jobst C., Peter, Sylvia, Günther, Christine, Volk, Hans-Dieter, Grütz, Gerald, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno, Heinemann, Volker
Publicado 2017

Prognostic and Predictive Molecular Markers in Cholangiocarcinoma

por Pavicevic, Sandra, Reichelt, Sophie, Uluk, Deniz, Lurje, Isabella, Engelmann, Cornelius, Modest, Dominik P., Pelzer, Uwe, Krenzien, Felix, Raschzok, Nathanael, Benzing, Christian, Sauer, Igor M., Stintzing, Sebastian, Tacke, Frank, Schöning, Wenzel, Schmelzle, Moritz, Pratschke, Johann, Lurje, Georg
Publicado 2022

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic co...

por Giessen, Clemens, von Weikersthal, Ludwig Fischer, Hinke, Axel, Stintzing, Sebastian, Kullmann, Frank, Vehling-Kaiser, Ursula, Mayerle, Julia, Bangerter, Markus, Denzlinger, Claudio, Sieber, Markus, Teschendorf, Christian, Freiberg-Richter, Jens, Schulz, Christoph, Modest, Dominik Paul, Moosmann, Nicolas, Aubele, Philipp, Heinemann, Volker
Publicado 2011

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

por Ohnmacht, Alexander J., Stahler, Arndt, Stintzing, Sebastian, Modest, Dominik P., Holch, Julian W., Westphalen, C. Benedikt, Hölzel, Linus, Schübel, Marisa K., Galhoz, Ana, Farnoud, Ali, Ud-Dean, Minhaz, Vehling-Kaiser, Ursula, Decker, Thomas, Moehler, Markus, Heinig, Matthias, Heinemann, Volker, Menden, Michael P.
Publicado 2023

Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306)

por Modest, Dominik Paul, Stintzing, Sebastian, von Weikersthal, Ludwig Fischer, Decker, Thomas, Kiani, Alexander, Vehling-Kaiser, Ursula, Al-Batran, Salah-Eddin, Heintges, Tobias, Kahl, Christoph, Seipelt, Gernot, Kullmann, Frank, Scheithauer, Werner, Moehler, Markus, Holch, Julian Walter, von Einem, Jobst Christian, Held, Swantje, Heinemann, Volker
Publicado 2017

Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306

por Modest, Dominik Paul, Heinemann, Volker, Folprecht, Gunnar, Denecke, Timm, Pratschke, Johann, Lang, Hauke, Bemelmans, Marc, Becker, Thomas, Rentsch, Markus, Seehofer, Daniel, Bruns, Christiane J., Gebauer, Bernhard, Held, Swantje, Stahler, Arndt, Heinrich, Kathrin, von Einem, Jobst C., Stintzing, Sebastian, Neumann, Ulf P., Ricard, Ingrid
Publicado 2020